Copyright 1998 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
To the Editor.—Physicians should be alerted to the unfortunate choice of names for the smoking cessation drug, Zyban or bupropion hydrochloride. Zyban (Grace-Sierra Co, Malpitas, Calif) is also the trade name for thiophanate with mancozeb, one of the few fungicides still approved and widely used in many areas of the United States for residential and nursery applications (Figure 1). An active metabolite of Zyban (for horticulture use) is a benzimidazole that binds β-tubulin and inhibits microtubule function. The benzimidazoles bind only weakly to mammalian tubulin, but nevertheless have been classified as potential human carcinogens based on animal studies.1 - 2 Mancozeb, a dithiocarbamate fungicide, has both mutagenic and teratogenic properties.3 - 4
Product label for the fungicide dimethyl 4,4′-o-phenylene bis (3-thioallophanate) with carbamic acid, ethylene bis (dithio)-mangenese zinc complex.
In my academic-based clinic, with a largely referral population from rural, northern Florida, I have already had patients express surprise that I would recommend a product for smoking cessation that was originally intended for agricultural use. Worse still, most agricultural workers will be aware that benzimidazoles also have been widely used as antihelminthic drugs in animals, so an extension to human use might be anticipated. Given the large number of people who seek economy in medications by obtaining prescription drugs from nonphysician sources, and the even larger number of people exposed to the advertising blitz directed at the general public by the manufacturer of the pharmaceutical Zyban, it is possible that some patients will find the fungicide, Zyban, conveniently sitting on a shelf with their other out-of-reach gardening, pesticide, and veterinary supplies, and use it as a substitute for bupropion.
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.